1. Home
  2. AFMD vs DTSS Comparison

AFMD vs DTSS Comparison

Compare AFMD & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • DTSS
  • Stock Information
  • Founded
  • AFMD 2000
  • DTSS 2014
  • Country
  • AFMD Germany
  • DTSS China
  • Employees
  • AFMD N/A
  • DTSS N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • DTSS Computer Software: Prepackaged Software
  • Sector
  • AFMD Health Care
  • DTSS Technology
  • Exchange
  • AFMD Nasdaq
  • DTSS Nasdaq
  • Market Cap
  • AFMD 14.5M
  • DTSS 14.2M
  • IPO Year
  • AFMD 2014
  • DTSS N/A
  • Fundamental
  • Price
  • AFMD $0.72
  • DTSS $2.17
  • Analyst Decision
  • AFMD Strong Buy
  • DTSS
  • Analyst Count
  • AFMD 5
  • DTSS 0
  • Target Price
  • AFMD $13.50
  • DTSS N/A
  • AVG Volume (30 Days)
  • AFMD 86.2K
  • DTSS 64.2K
  • Earning Date
  • AFMD 04-08-2025
  • DTSS 05-12-2025
  • Dividend Yield
  • AFMD N/A
  • DTSS N/A
  • EPS Growth
  • AFMD N/A
  • DTSS N/A
  • EPS
  • AFMD N/A
  • DTSS N/A
  • Revenue
  • AFMD $6,287,085.00
  • DTSS $47,284,153.00
  • Revenue This Year
  • AFMD N/A
  • DTSS N/A
  • Revenue Next Year
  • AFMD $225.65
  • DTSS N/A
  • P/E Ratio
  • AFMD N/A
  • DTSS N/A
  • Revenue Growth
  • AFMD N/A
  • DTSS 117.51
  • 52 Week Low
  • AFMD $0.70
  • DTSS $1.65
  • 52 Week High
  • AFMD $8.95
  • DTSS $9.78
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 30.95
  • DTSS 48.67
  • Support Level
  • AFMD $0.85
  • DTSS $2.14
  • Resistance Level
  • AFMD $0.89
  • DTSS $2.44
  • Average True Range (ATR)
  • AFMD 0.05
  • DTSS 0.14
  • MACD
  • AFMD -0.01
  • DTSS 0.01
  • Stochastic Oscillator
  • AFMD 22.75
  • DTSS 18.46

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About DTSS Datasea Inc.

Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.

Share on Social Networks: